Primary cardiac composite hemangioendothelioma with calcification mimicking a right atrial myxoma: A rare entity

Xiang Zhou1, Hongyan Liu1, Jiahui He2

  • 1Department of Cardiac Surgery, Wuhan Asia Heart Hospital, Wuhan, China.

Journal of Cardiac Surgery
|September 8, 2022
PubMed

Insights

Composite hemangioendothelioma (CHE), a rare vascular tumor, typically affects skin and soft tissues. This report details an exceptionally rare case of CHE occurring within the heart, highlighting its unusual presentation.

Area of Science:

  • Cardiovascular Pathology
  • Vascular Oncology
  • Rare Tumor Research

Background:

  • Composite hemangioendothelioma (CHE) is a rare vascular neoplasm characterized by a mix of benign, low-grade, and malignant vascular elements.
  • CHE commonly presents as a superficial tumor on the extremities, involving the dermis and subcutaneous tissue.

Observation:

  • This study documents an atypical presentation of composite hemangioendothelioma.
  • The tumor was identified within the cardiac structure, a location rarely associated with this condition.

Findings:

  • The case confirms the possibility of intra-cardiac occurrence of composite hemangioendothelioma.
  • Pathological analysis revealed the characteristic mixed vascular components of CHE within the heart.

Implications:

  • This finding expands the known anatomical distribution of composite hemangioendothelioma.
  • It underscores the importance of considering rare vascular tumors in cardiac differential diagnoses.
  • Further research may elucidate the specific mechanisms and clinical behavior of cardiac CHE.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
28
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
47
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
22
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
42